Edition:
United States

Terumo Corp (4543.T)

4543.T on Tokyo Stock Exchange

3,950JPY
24 Feb 2017
Change (% chg)

¥-25 (-0.63%)
Prev Close
¥3,975
Open
¥3,975
Day's High
¥3,975
Day's Low
¥3,925
Volume
890,600
Avg. Vol
1,285,516
52-wk High
¥4,840
52-wk Low
¥3,820

Select another date:

Thu, Feb 9 2017

BRIEF-Terumo buys back 11 mln shares for 44.22 bln yen

* Says it completed share repurchase plan disclosed on Feb. 9, with a result of 11 million shares repurchased for 44.22 billion yen

BRIEF-Terumo names Takahito Mimura as chairman and Shinjiro Sato as president

Feb 9 Terumo Corp: * Says the co names Takahito Mimura as chairman of the board * Says the co names Shinjiro Sato as president and CEO * Says effective on April 1 Source text in Japanese:https://goo.gl/mpOLIG Further company coverage: (Beijing Headline News)

BRIEF-Terumo to buy back 11 mln shares for 50 bln yen via ToSTNeT-3

* Says the co plans to buy back up to 11 million shares(3.03 percent stake) for no more than 50 billion yen via ToSTNeT-3 on Feb. 10

BRIEF-Olympus, Terumo to dissolve capital alliance

* Olympus says to sell its entire 2.48 pct stake in Terumo back to Terumo

BRIEF-Terumo's first-half operating profit likely rose 2 pct to roughly 40 bln yen - Nikkei

* Terumo's first-half operating profit likely rose 2 pct on the year to roughly 40 billion yen ($388 million) - Nikkei

Terumo shares up 2 percent on news it will buy U.S. firms' medical devices

TOKYO Shares of Terumo Corp rose on Wednesday morning after two U.S. companies said they will sell some of their medical devices to the Japanese medical equipment maker.

BRIEF-St. Jude and Abbott to divest two businesses to Terumo Corp

* St. Jude Medical and Abbott to sell portion of vascular closure and electrophysiology businesses to Terumo Corporation

BRIEF-Terumo is set to substantially reduce foreign exchange losses this fiscal year - Nikkei

* Terumo Corp is set to substantially reduce foreign exchange losses this fiscal year - Nikkei

BRIEF-Terumo Corp looks to purchase portion of Abbott Laboratories' medical device business - Nikkei

* Terumo Corp is looking to purchase a portion of Abbott Laboratories' medical device business - Nikkei

BRIEF-Terumo to inject $300 mln in Singapore firm Terumo Capital Management Pte. Ltd

* Says the co plans to inject up to $300 million in Singapore-based company, Terumo Capital Management Pte. Ltd

Select another date:

More From Around the Web